September 19, 2021

Volume XI, Number 262

Advertisement

September 17, 2021

Subscribe to Latest Legal News and Analysis

September 16, 2021

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Date Title Organization
8
Jul
China’s National Intellectual Property Administration Releases Patent Linkage Administrative Adjudication Measures Schwegman, Lundberg & Woessner, P.A.
8
Jul
Transparency in Prescription Drug Pricing: Recent State and Federal Developments to Watch Greenberg Traurig, LLP
7
Jul
340B Update: Delaware Court Denies 340B Program Statute Requiring Contract Pharmacy Arrangements K&L Gates
7
Jul
Mexico’s Supreme Court Finds General Health Law Articles Prohibiting Recreational Use of Marijuana Unconstitutional Greenberg Traurig, LLP
7
Jul
House Asks FDA to Clarify Plant-Based Food Labels Keller and Heckman LLP
6
Jul
The Supreme Court of Justice Authorized the Recreational Use of Cannabis OLIVARES
6
Jul
China Releases Patent Linkage Implementation Measures Schwegman, Lundberg & Woessner, P.A.
6
Jul
EC Requests Scientific Opinion on Fullerenes and Hydroxylated Fullerenes Bergeson & Campbell, P.C.
6
Jul
7th Circuit Affirms Summary Judgment in Favor of Defendant Champion Petfoods Keller and Heckman LLP
2
Jul
340B Drug Pricing Discount Program Update: HRSA Now Demands That Drug Manufacturers Provide 340B Discounts To Contract Pharmacies Amid Ongoing Litigation Sheppard, Mullin, Richter & Hampton LLP
2
Jul
FDA Releases Cyclospora Action Plan Keller and Heckman LLP
1
Jul
More than Innovation and Competition: The Latest Proposed Monitoring and Enforcement Mechanisms Targeting Foreign Influence in U.S. Research K&L Gates
1
Jul
Failure To State Cost Of Confirmatory Re-Test Violates Iowa Drug Testing Law Jackson Lewis P.C.
1
Jul
EC Committee Needs More Data to Assess Safety of the Nanomaterials Gold, Colloidal Gold, and Surface Modified Gold Bergeson & Campbell, P.C.
1
Jul
Connecticut and Vermont Ban PFAS in Food Packaging Keller and Heckman LLP
1
Jul
Marijuana Use Laws Budding In Virginia On July 1, 2021 Jackson Lewis P.C.
1
Jul
FDA Issues Update on Testing of PFAS in Food Keller and Heckman LLP
30
Jun
Court Decision Means that Antibody Patenting Is Not Getting Easier Bradley Arant Boult Cummings LLP
30
Jun
Update on Tobacco-Related Spring 2021 Unified Agenda of Regulatory and Deregulatory Actions Keller and Heckman LLP
30
Jun
FDA Releases List of Draft & Final Guidance Topics Keller and Heckman LLP

Pages

Advertisement
Advertisement